MedTrace Logo

Fibre suppLements fOR Pre-diAbetes - An Assessment Oral Fibre Supplements on Pre-diabetes Outcome Measures

NCT05593926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-01-17

No results posted yet for this study

Summary

This trial will investigate whether a powdered fibre mix helps maintain healthy blood glucose levels in participants with pre-diabetes, where high blood sugar is a risk of diabetes.

Conditions

  • Pre-diabetes

Interventions

DIETARY_SUPPLEMENT

Myota Metabolic Regulator

The functional food, Myota Metabolic Regulator, consisting of 20g of a powdered fibre mix, to be taken daily alongside usual diet for 24 weeks.

Sponsors & Collaborators

  • Lindus Health

    collaborator INDUSTRY

  • Myota GmbH

    lead INDUSTRY

Principal Investigators

  • Luke Twelves, Dr · Myota GmbH

  • Thomas Gurry, PhD · Myota GmbH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2023-08-26
Completion
2024-01-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593926 on ClinicalTrials.gov